SFX by Ex Libris Inc.

Title:	Isolation, Structure Elucidation, and Biological Activity of Virgineone fromLachnum virgineumUsing the Genome-WideCandida albicansFitness Test
Source:	Journal of Natural Products [0163-3864] Ondeyka, John yr:2009

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Akins, Robert A A. "An update on antifungal targets and mechanisms of resistance in Candida albicans." Medical mycology 43.4 (2005): 285-318.
description	2.	Odds, Frank C C. "Antifungal agents: mechanisms of action." Trends in microbiology 11.6 (2003): 272-9.
description	3.	Sanglard, D. "Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences." The Lancet infectious diseases 2.2 (2002): 73-85.
description	4.	Kumamoto, Carol A A. "Alternative Candida albicans lifestyles: Growth on surfaces." Annual review of microbiology 59.1 (2005): 113-133.
description	5.	Calderone, R. "Candida albicans : adherence, signaling and virulence." Medical mycology 38 Suppl 1.1 (2000): 125-37.
description	6.	Pasrija, R. "Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans." The journal of antimicrobial chemotherapy 55.6: 905-913.
description	7.	Ghannoum, M. "Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance." Clinical microbiology reviews 12.4 (1999): 501-517.
description	8.	Roling, Ellen E E. "Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods." Diagnostic Microbiology and Infectious Disease 43.1 (2002): 13-7.
description	9.	Noble, S. "Diagnosis and management of common tinea infections." American Family Physician 58.1 (1998): 163-174.
description	10.	Toke, O. "Antimicrobial peptides: New candidates in the fight against bacterial infections." Biopolymers 80.6 (2005): 717-735.
description	11.	Meunier, F. "Candidiasis." European journal of clinical microbiology & infectious diseases 8.5 (1989): 438-47.
description	12.	Whiteway, M. "Morphogenesis in Candida albicans." Annual Review of Microbiology 61.1 (2007): 529-553.
description	13.	Hitchcock, Y. "Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans." Gene 236.1 (1999): 43-51.
description	14.	Akdis, M. "The cellular orchestra in skin allergy; are differences to lung and nose relevant?" Current opinion in allergy and clinical immunology 10.5 (2010): 443-451.
description	15.	Jung, W. "Deletion of PDE2, the gene encoding the high-affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicans." Yeast 22.4 (2005): 285-294.
description	16.	Ma, B. "A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata." Proceedings of the National Academy of Sciences of the United States of America 104.18 (2007): 7628-7633.
description	17.	Jones, S. "Increased phenotypic switching in strains of Candida albicans associated with invasive infections." Journal of clinical microbiology (1994): 2869-2870.
description	18.	Markovich, S. "Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae." Antimicrobial agents and chemotherapy 48.10 (2004): 3871-6.
description	19.	Fonzi, W A A. "Virulence factors of Candida albicans." Trends in Microbiology 9.7 (2001): 327-35.
description	20.	Dupont, B. "Invasive aspergillosis." Medical mycology 38.1 (2000): 215-24.